Skip to main content
Top
Published in: International Journal of Legal Medicine 2/2011

01-03-2011 | Original Article

Buprenorphine and norbuprenorphine findings in hair during constant maintenance dosage

Authors: Gisela Skopp, Anja Kniest, Joerg Haisser, Karl Mann, Derik Hermann

Published in: International Journal of Legal Medicine | Issue 2/2011

Login to get access

Abstract

It is still a matter of debate whether a positive correlation between the dose and the amount of drug in the hair exists. Drugs such as buprenorphine (BUP) used under controlled conditions present an opportunity to prove a possible relationship. Due to discrepant findings of BUP/norbuprenorphine (NBUP) ratios in hair, in vitro degradation of both analytes in diluted acid was also investigated. The levels of BUP and NBUP in proximal hair sections from 18 subjects participating in a maintenance program were determined by liquid chromatography/tandem mass spectrometry following incubation with methanol and subsequent liquid/liquid extraction. BUP and NBUP were incubated in diluted hydrochloric acid at 60°C for up to 24 h. The alleged rearrangement products were simultaneously monitored. All hair samples tested positive for BUP (lower limit of detection–0.238 ng/mg hair) and NBUP (0.043–0.961 ng/mg hair). The concentration of NBUP in hair was consistently higher than that of BUP except for a single specimen. Degradation of BUP and NBUP was dependent on time; hydrolysis of NBUP occurred faster than that of BUP. The concentration of BUP and NBUP will be underestimated if analytes are recovered by acidic procedures. NBUP should be monitored in hair samples besides BUP for the sum of both BUP and NBUP may provide an estimate of BUP exposure following long-term administration of the drug.
Literature
1.
go back to reference Boumba VA, Ziavrou KS, Vougiouklakis T (2006) Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Int J Toxicol 25:143–161PubMedCrossRef Boumba VA, Ziavrou KS, Vougiouklakis T (2006) Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Int J Toxicol 25:143–161PubMedCrossRef
2.
go back to reference Goodwin RS, Wilkins DG, Averin O, Choo RE, Schroeder JR, Jasinski DR et al (2007) Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration. Clin Chem 53:2136–2143PubMedCrossRef Goodwin RS, Wilkins DG, Averin O, Choo RE, Schroeder JR, Jasinski DR et al (2007) Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration. Clin Chem 53:2136–2143PubMedCrossRef
3.
go back to reference Oechsler S, Skopp G (2010) An in vitro approach to estimate putative inhibition of buprenorphine and norbuprenorphine glucuronidation. Int J Legal Med 124:187–194PubMedCrossRef Oechsler S, Skopp G (2010) An in vitro approach to estimate putative inhibition of buprenorphine and norbuprenorphine glucuronidation. Int J Legal Med 124:187–194PubMedCrossRef
4.
5.
go back to reference Wilkins DG, Valdez AS, Nagasawa PR, Gygi SP, Rollins DE (1998) Incorporation of drugs for the treatment of substance abuse into pigmented and nonpigmented hair. J Pharm Sci 67:435–440CrossRef Wilkins DG, Valdez AS, Nagasawa PR, Gygi SP, Rollins DE (1998) Incorporation of drugs for the treatment of substance abuse into pigmented and nonpigmented hair. J Pharm Sci 67:435–440CrossRef
6.
go back to reference Negrusz A, Moore CM, Perry JL (1998) Detection of doxepin and its major metabolite desmethyldoxepin in hair following drug therapy. J Anal Toxicol 22:531–536PubMed Negrusz A, Moore CM, Perry JL (1998) Detection of doxepin and its major metabolite desmethyldoxepin in hair following drug therapy. J Anal Toxicol 22:531–536PubMed
7.
go back to reference Xiang P, Sun Q, Shen B, Shen M (2010) Disposition of ketamine and norketamine in hair after a single dose. Int J Legal Med [Epub ahead of print] PMID: 21153031 Xiang P, Sun Q, Shen B, Shen M (2010) Disposition of ketamine and norketamine in hair after a single dose. Int J Legal Med [Epub ahead of print] PMID: 21153031
8.
go back to reference Kuhlmann JJ, Lalani S, Magluilo J, Levine B, Darwin WD, Johnson RE et al (1996) Human pharmacokinetics of intravenous, sublingual and buccal buprenorphine. J Anal Toxicol 20:369–378 Kuhlmann JJ, Lalani S, Magluilo J, Levine B, Darwin WD, Johnson RE et al (1996) Human pharmacokinetics of intravenous, sublingual and buccal buprenorphine. J Anal Toxicol 20:369–378
9.
go back to reference Yassen A, Kan J, Olofsen E, Suidgeest E, Dahan A, Danhof M (2007) Pharmacokinetic–pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats. J Pharmacol Exp Ther 321:598–607PubMedCrossRef Yassen A, Kan J, Olofsen E, Suidgeest E, Dahan A, Danhof M (2007) Pharmacokinetic–pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats. J Pharmacol Exp Ther 321:598–607PubMedCrossRef
10.
go back to reference Cirimele V, Kintz P, Lohner S, Ludes B (2000) Buprenorphine to norbuprenorphine ratio in human hair. J Anal Toxicol 24:448–449 Cirimele V, Kintz P, Lohner S, Ludes B (2000) Buprenorphine to norbuprenorphine ratio in human hair. J Anal Toxicol 24:448–449
11.
go back to reference Zhou SF, Liul P, Chowbay B (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 41:89–295PubMedCrossRef Zhou SF, Liul P, Chowbay B (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 41:89–295PubMedCrossRef
12.
go back to reference Blom Y, Bondesson U (1985) Analysis of buprenorphine and its N-dealkylated metabolite in plasma and urine by selected-ion monitoring. J Chromatogr 338:89–98PubMedCrossRef Blom Y, Bondesson U (1985) Analysis of buprenorphine and its N-dealkylated metabolite in plasma and urine by selected-ion monitoring. J Chromatogr 338:89–98PubMedCrossRef
13.
go back to reference Kintz P, Villain M, Tracqui A, Cirimele V, Ludes B (2003) Buprenorphine in drug-facilitated sexual abuse: a fatal case involving a 14-year-old boy. J Anal Toxicol 27:527–529PubMed Kintz P, Villain M, Tracqui A, Cirimele V, Ludes B (2003) Buprenorphine in drug-facilitated sexual abuse: a fatal case involving a 14-year-old boy. J Anal Toxicol 27:527–529PubMed
14.
go back to reference Tracqui A, Kintz P, Mangin P (1997) HPLC–MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples. J Forensic Sci 42:111–114PubMed Tracqui A, Kintz P, Mangin P (1997) HPLC–MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples. J Forensic Sci 42:111–114PubMed
15.
go back to reference Favretto D, Frison G, Vogliardi S, Ferrara SD (2006) Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine and nor-buprenorphine in urine, blood and hair samples. Rapid Commun Mass Spectrom 20:1257–1268PubMedCrossRef Favretto D, Frison G, Vogliardi S, Ferrara SD (2006) Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine and nor-buprenorphine in urine, blood and hair samples. Rapid Commun Mass Spectrom 20:1257–1268PubMedCrossRef
16.
go back to reference Borriello R, Gargiulo L, Cassandra P (2008) Buprenorphine and norbuprenorphine determination by GC/MS in putrefied biological samples: evaluation of a buprenorphine related death. Ann Toxicol Anal 20:117–119CrossRef Borriello R, Gargiulo L, Cassandra P (2008) Buprenorphine and norbuprenorphine determination by GC/MS in putrefied biological samples: evaluation of a buprenorphine related death. Ann Toxicol Anal 20:117–119CrossRef
17.
go back to reference Vincent F, Bessard J, Vacheron J, Mallaret M, Bessard G (1999) Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography–mass spectrometry. J Anal Toxicol 23:270–279PubMed Vincent F, Bessard J, Vacheron J, Mallaret M, Bessard G (1999) Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography–mass spectrometry. J Anal Toxicol 23:270–279PubMed
18.
go back to reference Skopp G, Strohbeck-Kuehner P, Mann K, Hermann D (2007) Deposition of cannabinoids in hair after long-term use of cannabis. Forensic Sci Int 170:46–50PubMedCrossRef Skopp G, Strohbeck-Kuehner P, Mann K, Hermann D (2007) Deposition of cannabinoids in hair after long-term use of cannabis. Forensic Sci Int 170:46–50PubMedCrossRef
19.
go back to reference Poetsch L, Eser HP, Skopp G, Moeller MR (1998) Zum Suchtmittelnachweis in Haaren. VII: Untersuchungen bei Methadonpatienten unter konstanter Wirkstoffeinnahme. Rechtsmedizin 8:47–50CrossRef Poetsch L, Eser HP, Skopp G, Moeller MR (1998) Zum Suchtmittelnachweis in Haaren. VII: Untersuchungen bei Methadonpatienten unter konstanter Wirkstoffeinnahme. Rechtsmedizin 8:47–50CrossRef
Metadata
Title
Buprenorphine and norbuprenorphine findings in hair during constant maintenance dosage
Authors
Gisela Skopp
Anja Kniest
Joerg Haisser
Karl Mann
Derik Hermann
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
International Journal of Legal Medicine / Issue 2/2011
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-011-0555-8

Other articles of this Issue 2/2011

International Journal of Legal Medicine 2/2011 Go to the issue